Trade Setup for November 25: Nifty remains in a range but broader market pain may dampen sentiments

Markets opened on a strong note, with Nifty gaining about 50 points on firm global cues. However, selling pressure intensified through the day.

Markets opened on a strong note, with Nifty gaining about 50 points on firm global cues. However, selling pressure intensified through the day.

Praveena Rai, Managing Director at MCX, said the October 28 trading glitch was swiftly addressed with a root-cause analysis, third-party review, and ongoing stress tests. She added that an expert panel is assessing the platform’s scalability and resilience as the…

AWS doesn’t disclose the locations of individual data centers for security reasons and to keep operational details out of the hands of competitors. The documents shine a light on Amazon’s cloud computing operations at a time when investors are keen…

The total cryptocurrency market cap has fallen by $1.7 trillion from the highs of 2025 — a sign of just how deep the correction has been.

Dr Reddy’s has secured European Commission approval for AVT03, its biosimilar version of Prolia and Xgeva—medicines used to treat osteoporosis and prevent bone complications in cancer patients.

The contract value stands at ₹58.5 crore annually for 35 years as yearly transmission charges. Shares of Ceigall India Ltd ended at ₹239.95, down by ₹2.25, or 0.93%, on the BSE today, November 24.

The benchmark 10-year bond yield fell four basis points to 6.48% after the comments.

Novo shares plunged as much as 12.4% in Copenhagen, hitting the lowest level since July 2021. Their value has more than halved this year amid investor concerns over Novo’s long-term competitiveness in obesity, a booming market it helped create.

Jairam Sridharan, MD & CEO of Piramal Finance and Krishnan Sitaraman, Chief Ratings Officer at Crisil Ratings discuss NBFC sector growth, rising LAP risks, funding pressures, and the outlook for margins and asset quality.

Talks are at an early stage, and no decision has been made on the size of the offering. The move marks Sembcorp’s second attempt to list its India business after withdrawing a draft prospectus in January 2019 to inject new…